Berney T et al. |
Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations. |
2004 |
Transplant. Proc. |
pmid:15194390
|
Gonzalez Molina M et al. |
Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine. |
2007 |
Transplant. Proc. |
pmid:17889126
|
Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Kobayashi M et al. |
HLA-DR matching effect in orthotopic liver transplantation under FK 506. |
1993 |
Transplant. Proc. |
pmid:7679812
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Ueki M et al. |
Peritoneal-omental pouch as a site for islet allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7513462
|
Strasser S et al. |
The effect of FK 506 on canine pancreatic islet cell function in beagle dogs. |
1991 |
Transplant. Proc. |
pmid:1703709
|
Masutani K et al. |
Protocol biopsy findings in living donor kidney transplant patients treated with once-daily or twice-daily tacrolimus formulation. |
2014 |
Transplant. Proc. |
pmid:24655972
|
Gavela E et al. |
Histological findings of early graft biopsies in old donor renal transplant patients receiving induction therapy. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715842
|
Cherala G et al. |
Tacrolimus pharmacokinetics in Hispanic children after kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:22172831
|
Spinelli GA et al. |
Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen. |
2011 |
Transplant. Proc. |
pmid:22172836
|
Latorre A et al. |
Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959186
|
Stringa P et al. |
Pretreatment Combination Reduces Remote Organ Damage Secondary to Intestinal Reperfusion Injury in Mice: Follow-up Study. |
|
Transplant. Proc. |
pmid:26915870
|
Soda M et al. |
Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms. |
|
Transplant. Proc. |
pmid:28736028
|
Mac Guad R et al. |
Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:26915847
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Burke GW et al. |
Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. |
1998 |
Transplant. Proc. |
pmid:9532223
|
Shimizu T et al. |
Risk factors of acute tacrolimus nephrotoxicity in renal allografts. |
2000 |
Transplant. Proc. |
pmid:11119998
|
Bonet H et al. |
Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. |
1993 |
Transplant. Proc. |
pmid:7680145
|
Chueh SC et al. |
Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report. |
2000 |
Transplant. Proc. |
pmid:11120003
|
Lauro A et al. |
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908252
|
Fung J et al. |
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7680146
|
Pichard L et al. |
Effect of FK 506 on human hepatic cytochromes P-450: interaction with CyA. |
1991 |
Transplant. Proc. |
pmid:1721279
|
Christians U et al. |
Interactions of FK 506 and cyclosporine metabolism. |
1991 |
Transplant. Proc. |
pmid:1721280
|
Takeda M et al. |
Methotrexate in rescue therapy for xenotransplanted lungs in primates. |
1996 |
Transplant. Proc. |
pmid:8623402
|
Burkhalter F et al. |
High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study. |
2012 |
Transplant. Proc. |
pmid:23195006
|
Andereggen E et al. |
Immunohistological study of islet xenograft rejection in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623420
|
Charco R et al. |
Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation. |
2005 |
Transplant. Proc. |
pmid:16386588
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Kawauchi M et al. |
Cardiac xenotransplantation from pig to Japanese monkey with splenectomy, tacrolims, filtration plasmapheresis, and nafamstat mesilate. |
1994 |
Transplant. Proc. |
pmid:7518105
|
Oppenheimer F |
Steroid withdrawal in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10686314
|
Platz KP et al. |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. |
1995 |
Transplant. Proc. |
pmid:7533357
|
Hairhara Y et al. |
Effect of fluconazole on blood levels of tacrolimus. |
1999 |
Transplant. Proc. |
pmid:10578284
|
Andersson J et al. |
The effects of FK 506 on cytokine production are dependent on the mode of cell activation. |
1991 |
Transplant. Proc. |
pmid:1721311
|
Tamura A et al. |
Combination effect of tacrolimus and FTY720 in liver transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10578290
|
Jain A et al. |
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. |
2005 |
Transplant. Proc. |
pmid:15848671
|
Florman S et al. |
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. |
2005 |
Transplant. Proc. |
pmid:15848672
|
Imai K et al. |
Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1697117
|
Chen J et al. |
Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy. |
2008 |
Transplant. Proc. |
pmid:18589119
|
Marcén R et al. |
Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study. |
2006 |
Transplant. Proc. |
pmid:17097957
|
Kawano K et al. |
Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. |
1995 |
Transplant. Proc. |
pmid:7533410
|
Akita K and Mandel TE |
Effect of FK 506 and anti-CD4 monoclonal antibody treatment on xenografts of organ-cultured fetal pig pancreas and host lymphoid populations. |
1993 |
Transplant. Proc. |
pmid:7692650
|
Tanabe M et al. |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. |
1995 |
Transplant. Proc. |
pmid:7533411
|
Tzakis AG et al. |
FK 506 versus cyclosporine in pediatric liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721343
|
Borrows R et al. |
Steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil: three-year results. |
2005 |
Transplant. Proc. |
pmid:15919468
|
Mieles LA et al. |
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. |
1991 |
Transplant. Proc. |
pmid:1721344
|
Gozdowska J et al. |
Safety and tolerance of sodium mycophenolate in patients after renal transplantation--an observational study. |
2009 |
Transplant. Proc. |
pmid:19857665
|
Varo E et al. |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. |
2002 |
Transplant. Proc. |
pmid:12176481
|
Odoul F et al. |
Massive ingestion of tacrolimus in a young liver transplant patient. |
1998 |
Transplant. Proc. |
pmid:9865375
|
Cronin DC et al. |
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123010
|
Rossi G et al. |
Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907932
|
|
Morphopathological findings of renal allografts under FK 506 therapy. Japanese FK 506 Study Group. |
1994 |
Transplant. Proc. |
pmid:7520614
|
Choi JY and Kwon OJ |
Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants? |
2013 |
Transplant. Proc. |
pmid:24156999
|
Morris SM et al. |
Disruption of renal function and gene expression by FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721375
|
Mange KC and Bloom RD |
Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12493393
|
Lagodziński Z et al. |
Effect of FK 506 on B-cell responses. |
1991 |
Transplant. Proc. |
pmid:1703359
|
Lieberman KV et al. |
FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS). |
1991 |
Transplant. Proc. |
pmid:1721376
|
Domenech N et al. |
Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients. |
2003 |
Transplant. Proc. |
pmid:12962873
|
Boots JM et al. |
Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation? |
2002 |
Transplant. Proc. |
pmid:12493409
|
Demetris AJ et al. |
Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703360
|
Peraira JR et al. |
High incidence of severe infections in heart transplant recipients receiving tacrolimus. |
2003 |
Transplant. Proc. |
pmid:12962875
|
Villanueva ME et al. |
Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation. |
2008 |
Transplant. Proc. |
pmid:18790198
|
Wayman MR et al. |
Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy. |
2002 |
Transplant. Proc. |
pmid:12176526
|
Cho WH et al. |
Basiliximab does not reduce the early rejection incidence in high-risk kidney recipients under tacrolimus-based immunosuppression. |
2008 |
Transplant. Proc. |
pmid:18790201
|
Okamoto M et al. |
Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center. |
2002 |
Transplant. Proc. |
pmid:12176527
|
Kaufman DB et al. |
Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083261
|
Stratta RJ |
Optimal immunosuppression in pancreas transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083263
|
Limsrichamrern S et al. |
Correlation of Hematocrit and Tacrolimus Level in Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27320581
|
Guo Z et al. |
Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123314
|
Walgenbach KJ et al. |
Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123418
|
Golling M et al. |
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962234
|
Pirsch JD et al. |
Pulmonary infiltrates and eosinophilia in an FK 506 liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721406
|
Wada H et al. |
Combination use of suboptimal doses of FK 506 and cyclosporine in canine lung transplantation. |
1992 |
Transplant. Proc. |
pmid:1379758
|
Schweizer RT and Meisterling LD |
Tolerability of mycophenolate mofetil in organ transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377540
|
Pham SM et al. |
Sirolimus and tacrolimus in clinical cardiac transplantation. |
2002 |
Transplant. Proc. |
pmid:12176597
|
Zhou J et al. |
Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria. |
2008 |
Transplant. Proc. |
pmid:19100435
|
Ciancio G et al. |
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267169
|
Vincenti F |
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267172
|
Gridelli B et al. |
Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723311
|
Lagget M et al. |
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients. |
1998 |
Transplant. Proc. |
pmid:9723312
|
Ghio L et al. |
Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report. |
2004 |
Transplant. Proc. |
pmid:15251325
|
DeValeria PA et al. |
FK 506 fails to reverse moderate cardiac allograft rejection in a canine heterotopic model. |
1991 |
Transplant. Proc. |
pmid:1721438
|
Grabczewska Z et al. |
Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index. |
2013 |
Transplant. Proc. |
pmid:23726621
|
Jiang H et al. |
Prolonged cardiac allograft survival in sensitized rats by low-dose FK 506 in combination with splenectomy. |
1991 |
Transplant. Proc. |
pmid:1721439
|
Murase N et al. |
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. |
1987 |
Transplant. Proc. |
pmid:2445081
|
Makowka L et al. |
The effect of FK-506 on hyperacute rejection in presensitized rats. |
1987 |
Transplant. Proc. |
pmid:2445082
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
Pankewycz O et al. |
Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study. |
2011 |
Transplant. Proc. |
pmid:21440749
|
GarcÃa González M et al. |
Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500620
|
Fu Q et al. |
Risk Factors for Acute Rejection After Deceased Donor Kidney Transplantation in China. |
2018 |
Transplant. Proc. |
pmid:30316380
|
Konno O et al. |
Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine. |
2018 |
Transplant. Proc. |
pmid:30316378
|
Pinho-Apezzato ML et al. |
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. |
2010 |
Transplant. Proc. |
pmid:20620519
|
Calne RY |
Immunosuppression for organ grafting. |
1991 |
Transplant. Proc. |
pmid:1714646
|
Rodriguez Cubillo B et al. |
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. |
2016 |
Transplant. Proc. |
pmid:27932117
|
Kinukawa T et al. |
Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. |
1998 |
Transplant. Proc. |
pmid:9636498
|
Morris-Stiff G et al. |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636499
|
Alak AM and Moy S |
Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients. |
1997 |
Transplant. Proc. |
pmid:9270821
|
Scholler G et al. |
Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation. |
1997 |
Transplant. Proc. |
pmid:9270822
|
Nielsen FT et al. |
Nephrotoxity of FK 506: a preliminary study on comparative aspects of FK 506 and cyclosporine nephrotoxicity. |
1994 |
Transplant. Proc. |
pmid:7527946
|
Fisher A et al. |
Gastrointestinal toxicity associated with FK 506 in liver transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7527947
|